There may be a link between saline-and silicone gel-filled breast implants and anaplastic large cell lymphoma (ALCL), a rare type of cancer.
That’s according to the U.S. Food and Drug Administration (FDA), which announced the possible, “small but significant risk” in January after conducting a sweeping review of data on cases of ALCL in women with breast implants. In most of the cases, patients were diagnosed with ALCL after developing symptoms such as pain, lumps, or swelling due to collection of fluid, hardening of breast area around the implant, or masses surrounding the implant.
William Maisel, the chief scientist and deputy director for science in the FDA’s Center for Devices and Radiological Health, said in an agency press release that more data from health care professionals is needed to determine whether breast implants can indeed result in ALCL. In the meantime, the FDA wants patients to know: there is a potential danger here.
Do you believe that you were harmed by a breast implant or other medical product? Contact Hodes Milman Liebeck for a free case evaluation. We’re aggressive personal injury and medical malpractice lawyers based in Orange County, serving all of California. We have the experience to take on the medical industry and have achieved multi-million dollar verdicts for our clients.